sleep-disorders

ncbi.nlm.nih.gov

Apnimed Prepares FDA Filing for Sleep Apnea Pill

Apnimed plans to seek FDA approval for a nightly pill developed from two existing drugs. The treatment aims to address obstructive sleep apnea, which affects up to 80 million people in the U.S.